MARKET

MANE

MANE

VERADERMICS INC
NYSE
63.15
+2.30
+3.78%
Pre Market: 63.10 -0.05 -0.08% 06:03 04/01 EDT
OPEN
61.44
PREV CLOSE
60.85
HIGH
66.53
LOW
59.30
VOLUME
22
TURNOVER
--
52 WEEK HIGH
69.41
52 WEEK LOW
32.00
MARKET CAP
2.36B
P/E (TTM)
-29.6799
1D
5D
1M
3M
1Y
5Y
1D
Veradermics (VDPHL01): Accelerating Hair Loss Outcomes and Social Listening Insights Support Buy/High-Risk Rating and $85 Target
TipRanks · 23h ago
Tango Therapeutics is the best performing healthcare stock in March
Seeking Alpha · 1d ago
Veradermics Stock Falls 8% After Reporting Wider Loss In Q4, FY25
NASDAQ · 1d ago
Veradermics Q4 EPS $(0.62) Beats $(0.66) Estimate
Benzinga · 1d ago
Veradermics reports Q4 results
Seeking Alpha · 1d ago
Veradermics reports Q4 net loss $21.8M vs $5.7M last year
TipRanks · 1d ago
*Veradermics: Runway To Support Current Operating Plans Into 2029 >MANE
Dow Jones · 1d ago
Press Release: Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
Dow Jones · 1d ago
More
About MANE
Veradermics, Incorporated is a late clinical-stage biopharmaceutical company. The Company is focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Its initial focus is developing better treatments for pattern hair loss (PHL). The Company is developing VDPHL01 as an oral, non-hormonal treatment for men and women with PHL to reduce the barriers to wide adoption of chronic hair loss therapy and potentially transform PHL treatment. VDPHL01 is an oral, ER formulation of minoxidil, a proven hair growth agent, designed to maximize minoxidil’s impact on hair restoration while minimizing the risk of cardiac activity. The Company is conducting a Phase II clinical trial evaluating VDPHL01 in male and female patients with mild-to-moderate PHL.

Webull offers Veradermics Inc stock information, including NYSE: MANE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MANE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MANE stock methods without spending real money on the virtual paper trading platform.